NewGenIvf Group Limited Class A Ordinary Shares (NIVF) - Total Assets
Based on the latest financial reports, NewGenIvf Group Limited Class A Ordinary Shares (NIVF) holds total assets worth $35.56 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See NewGenIvf Group Limited Class A Ordinary net assets for net asset value and shareholders' equity analysis.
NewGenIvf Group Limited Class A Ordinary Shares - Total Assets Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's total assets have evolved over time, based on quarterly financial data.
NewGenIvf Group Limited Class A Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
NewGenIvf Group Limited Class A Ordinary Shares's total assets of $35.56 Million consist of 88.7% current assets and 11.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.8% |
| Accounts Receivable | $2.36 Million | 66.0% |
| Inventory | $80.81K | 2.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Class A Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of NewGenIvf Group Limited Class A Ordinary.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NewGenIvf Group Limited Class A Ordinary Shares's current assets represent 88.7% of total assets in 2024, an increase from 58.1% in 2021.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2024, up from 2.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 66.0% of total assets.
NewGenIvf Group Limited Class A Ordinary Shares Competitors by Total Assets
Key competitors of NewGenIvf Group Limited Class A Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
China | CN¥3.72 Billion |
|
WELL Health Technologies Corp
TO:WELL
|
Canada | CA$2.02 Billion |
|
Hospital Mater Dei S.A
SA:MATD3
|
Brazil | R$4.40 Billion |
|
MEDICLIN Aktiengesellschaft
XETRA:MED
|
Germany | €879.69 Million |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$22.48 Billion |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$163.53 Million |
NewGenIvf Group Limited Class A Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.43 | 0.28 | 0.65 |
| Quick Ratio | 3.37 | 0.21 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.93 Million | $-2.51 Million | $-41.01K |
NewGenIvf Group Limited Class A Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between NewGenIvf Group Limited Class A Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.03 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -83.2% |
| Total Assets | $3.58 Million |
| Market Capitalization | $789.85K USD |
Valuation Analysis
Below Book Valuation: The market values NewGenIvf Group Limited Class A Ordinary Shares's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NewGenIvf Group Limited Class A Ordinary Shares's assets decreased by 83.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NewGenIvf Group Limited Class A Ordinary Shares (2021–2024)
The table below shows the annual total assets of NewGenIvf Group Limited Class A Ordinary Shares from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.58 Million | -83.22% |
| 2023-12-31 | $21.32 Million | -69.88% |
| 2022-12-31 | $70.79 Million | +4910.49% |
| 2021-12-31 | $1.41 Million | -- |
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more